A Study to Evaluate the Pharmacokinetic Profiles and Safety of CKD-393(2) in Healthy Volunteers Under Fed Conditions
Clinical trial NCT05347576 · COMPLETED
Trial details
- NCT number
- NCT05347576
- Sponsor
- Chong Kun Dang Pharmaceutical
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2022-04-21
- Primary completion
- 2022-05-02
- Enrollment
- 31
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.